-

Fist Assist Announces CE Mark and European Launch

LOS ALTOS HILLS, Calif.--(BUSINESS WIRE)--Fist Assist Devices, LLC, has received CE Mark and has begun marketing the Fist Assist device for vein enhancement and enlargement in the European Union and other CE Mark countries. Fist Assist is the only wearable, patent protected, intermittent compression device to increase vein diameter prior to fistula placement and to assist in fistula vein dilation for hemodialysis for end stage renal disease (ESRD) patients.

We are thrilled to have received CE mark approval for Fist Assist. It is a huge milestone as we can now expand our commercialization efforts beyond India and into the European,” said Tej Singh MD, MBA, Chief Executive Officer and Founder of Fist Assist Devices, LLC . “This is a very exciting time for Fist Assist, patients and the European ESRD community. Our goal at Fist Assist is improve outcomes, lower costs, and improve the patients journey through ESRD by focusing on vein dilation and enhancement.”

“Fist Assist provides a patient focused evidence based approach to surgical vein enhancement for all types of arteriovenous fistulas and can be used to enhance veins before fistula creation as well as after surgery to improve maturation,” said Dr. Nick Inston, Specialist Vascular Access Surgeon at University Hospitals Birmingham, one of the largest renal/dialysis centres in Europe. “Access surgery and subsequent maturation is a major challenge and adjuncts to improve outcomes are desperately needed. Fist Assist is a creative solution which for the first time allows patients to be involved and directly influence their clinical outcomes with a comfortable and easy to use device.”

About Fist Assist

Fist Assist is a privately held company from Silicon Valley, CA that has developed the Fist Assist technology over the past 30 years. The Fist Assist technology is patent protected and is focused on developing and marketing an intermittent, external wearable pneumatic compression to increase forearm vein enhancement and AV fistula dilation. The Fist Assist device is currently only approved for sales in India and Europe. It is not yet commercially available in the United States at this time.

For further information, connect to www.fistassistdevices.com

Contacts

Tej Singh MD M.B.A
CEO & Founder
Fist Assist Devices, LLC
Tsingh@fistassistdevices.com
(650) 444-2599

Industry:

Fist Assist Devices, LLC

Release Versions
English

Contacts

Tej Singh MD M.B.A
CEO & Founder
Fist Assist Devices, LLC
Tsingh@fistassistdevices.com
(650) 444-2599

More News From Fist Assist Devices, LLC

Fist Assist Devices, LLC Announces Australian Distribution Deal and Sales Launch

LAS VEGAS--(BUSINESS WIRE)--Fist Assist Devices, LLC, announces a three-year affiliation with Regional Health Care Group to commercialize and launch sales of the Fist Assist Model FA-1 device in Australia and New Zealand. The Fist Assist Model FA-1 is a wearable, patent protected, intermittent compression device that has CE Mark clearance for use in those conditions where vein dilation is desired in patients that will require or already have undergone arteriovenous fistula placement for eventua...

Fist Assist Devices Receives FDA “Breakthrough Device” Designation for the World’s First Wearable Vein Dilation Device for ESRD Patients

LAS VEGAS--(BUSINESS WIRE)--Fist Assist Devices, LLC, an innovative medical device company focused on vein dilation to facilitate the Chronic Kidney Disease (CKD) patient’s journey through End-Stage Renal Disease (ESRD), announced today that it received “Breakthrough Device” designation from the U.S. Food and Drug Administration (FDA) for the Fist Assist Model FA-1 device. The FA-1 is the world’s first wearable device for pre-surgical vein dilation that promotes AV fistula creation in adult pat...

Fist Assist Devices, LLC Announces Release of the p-FACT Cohort Data

LOS ALTOS HILLS, Calif.--(BUSINESS WIRE)--Fist Assist Devices, LLC, announces that data associated with the p-FACT cohort, a data subset of the recently completed, non-significant risk Fist Assist Clinical Trial (FACT Trial) that focused on vein dilation in stage 4 patients with chronic renal failure, shows clear evidence that the Fist Assist device dilates the perforator vein. The p-FACT data derived from the FACT trial evaluated the use the FA-1 device developed by Fist Assist Devices, LLC, a...
Back to Newsroom